Cargando…

Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time

BACKGROUND: The symptoms of coronavirus disease 2019 (COVID-19) appear to be heterogenous, and the typical course of these symptoms is unknown. Our objectives were to characterize the common trajectories of COVID-19 symptoms and to assess how symptom course predicts other symptom changes as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodebaugh, Thomas L, Frumkin, Madelyn R, Reiersen, Angela M, Lenze, Eric J, Avidan, Michael S, Miller, J Philip, Piccirillo, Jay F, Zorumski, Charles F, Mattar, Caline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989225/
https://www.ncbi.nlm.nih.gov/pubmed/33796601
http://dx.doi.org/10.1093/ofid/ofab090
_version_ 1783668912733290496
author Rodebaugh, Thomas L
Frumkin, Madelyn R
Reiersen, Angela M
Lenze, Eric J
Avidan, Michael S
Miller, J Philip
Piccirillo, Jay F
Zorumski, Charles F
Mattar, Caline
author_facet Rodebaugh, Thomas L
Frumkin, Madelyn R
Reiersen, Angela M
Lenze, Eric J
Avidan, Michael S
Miller, J Philip
Piccirillo, Jay F
Zorumski, Charles F
Mattar, Caline
author_sort Rodebaugh, Thomas L
collection PubMed
description BACKGROUND: The symptoms of coronavirus disease 2019 (COVID-19) appear to be heterogenous, and the typical course of these symptoms is unknown. Our objectives were to characterize the common trajectories of COVID-19 symptoms and to assess how symptom course predicts other symptom changes as well as clinical deterioration. METHODS: One hundred sixty-two participants with acute COVID-19 responded to surveys up to 31 times for up to 17 days. Several statistical methods were used to characterize the temporal dynamics of these symptoms. Because 9 participants showed clinical deterioration, we explored whether these participants showed any differences in symptom profiles. RESULTS: Trajectories varied greatly between individuals, with many having persistently severe symptoms or developing new symptoms several days after being diagnosed. A typical trajectory was for a symptom to improve at a decremental rate, with most symptoms still persisting to some degree at the end of the reporting period. The pattern of symptoms over time suggested a fluctuating course for many patients. Participants who showed clinical deterioration were more likely to present with higher reports of severity of cough and diarrhea. CONCLUSIONS: The course of symptoms during the initial weeks of COVID-19 is highly heterogeneous and is neither predictable nor easily characterized using typical survey methods. This has implications for clinical care and early-treatment clinical trials. Additional research is needed to determine whether the decelerating improvement pattern seen in our data is related to the phenomenon of patients reporting long-term symptoms and whether higher symptoms of diarrhea in early illness presages deterioration.
format Online
Article
Text
id pubmed-7989225
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-79892252021-03-31 Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time Rodebaugh, Thomas L Frumkin, Madelyn R Reiersen, Angela M Lenze, Eric J Avidan, Michael S Miller, J Philip Piccirillo, Jay F Zorumski, Charles F Mattar, Caline Open Forum Infect Dis Major Articles BACKGROUND: The symptoms of coronavirus disease 2019 (COVID-19) appear to be heterogenous, and the typical course of these symptoms is unknown. Our objectives were to characterize the common trajectories of COVID-19 symptoms and to assess how symptom course predicts other symptom changes as well as clinical deterioration. METHODS: One hundred sixty-two participants with acute COVID-19 responded to surveys up to 31 times for up to 17 days. Several statistical methods were used to characterize the temporal dynamics of these symptoms. Because 9 participants showed clinical deterioration, we explored whether these participants showed any differences in symptom profiles. RESULTS: Trajectories varied greatly between individuals, with many having persistently severe symptoms or developing new symptoms several days after being diagnosed. A typical trajectory was for a symptom to improve at a decremental rate, with most symptoms still persisting to some degree at the end of the reporting period. The pattern of symptoms over time suggested a fluctuating course for many patients. Participants who showed clinical deterioration were more likely to present with higher reports of severity of cough and diarrhea. CONCLUSIONS: The course of symptoms during the initial weeks of COVID-19 is highly heterogeneous and is neither predictable nor easily characterized using typical survey methods. This has implications for clinical care and early-treatment clinical trials. Additional research is needed to determine whether the decelerating improvement pattern seen in our data is related to the phenomenon of patients reporting long-term symptoms and whether higher symptoms of diarrhea in early illness presages deterioration. Oxford University Press 2021-03-01 /pmc/articles/PMC7989225/ /pubmed/33796601 http://dx.doi.org/10.1093/ofid/ofab090 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles
Rodebaugh, Thomas L
Frumkin, Madelyn R
Reiersen, Angela M
Lenze, Eric J
Avidan, Michael S
Miller, J Philip
Piccirillo, Jay F
Zorumski, Charles F
Mattar, Caline
Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time
title Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time
title_full Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time
title_fullStr Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time
title_full_unstemmed Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time
title_short Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time
title_sort acute symptoms of mild to moderate covid-19 are highly heterogeneous across individuals and over time
topic Major Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989225/
https://www.ncbi.nlm.nih.gov/pubmed/33796601
http://dx.doi.org/10.1093/ofid/ofab090
work_keys_str_mv AT rodebaughthomasl acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime
AT frumkinmadelynr acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime
AT reiersenangelam acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime
AT lenzeericj acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime
AT avidanmichaels acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime
AT millerjphilip acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime
AT piccirillojayf acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime
AT zorumskicharlesf acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime
AT mattarcaline acutesymptomsofmildtomoderatecovid19arehighlyheterogeneousacrossindividualsandovertime